See if inflammation and scarring in Crohn's can be mapped from resected tissue
Official title: Virtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions
Run by Central Hospital, Nancy, France · NCT07413653 · Data updated 2026-11-12
This study tests whether detailed ex vivo MRI and tissue measurements on Crohn’s tissue removed during surgery can reveal inflammation versus fibrosis to guide future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Vandœuvre-lès-Nancy) |
| Status | Recruiting |
| Started | September 25, 2026 |
| Main results expected | October 1, 2027 |
| Study ends | October 1, 2028 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07413653 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with Crohn’s disease undergoing intestinal resection at CHRU Nancy who consent to reuse of their data and tissue for research.
✕Probably not a fit
Patients whose tissue samples do not yield informative MRI or histopathological correlations may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will perform comprehensive ex vivo multiparametric MRI on resected Crohn’s tissue, alongside biophysical measurements and histopathology, to map inflammation and fibrosis. The goal is to validate MRI biomarkers that could be used in living patients to tailor therapy and improve flare detection. The study uses tissue from adults undergoing intestinal resection at CHRU Nancy, focusing on precise tissue characterization beyond current imaging. This is an observational effort to correlate ex vivo findings with in vivo MRI signals. No interventions are being tested in this protocol.
Why it matters
Potential benefit: If successful, MRI biomarkers validated by this work could help clinicians distinguish reversible inflammation from irreversible fibrosis and personalize treatment decisions.
How similar studies have gone: Previous work in imaging and tissue characterization has shown promise in linking imaging features to pathology, but this exact ex vivo validation approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years. * Diagnosis of Crohn's disease and undergoing intestinal resection surgery at CHRU Nancy. * Patient has not objected to the reuse of personal data and biological samples for the purposes of this research. Exclusion Criteria: \- None
Where it's running
-
CHRU Nancy
Vandœuvre-lès-Nancy, France Recruiting
Study contacts
- Study coordinator: Guillaume DROUOT, PhD
- Email: g.drouot@chru-nancy.fr
- Phone: +33383157666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reduce ultra-processed foods to help kids with Crohn's stay in remission longer
This study tests whether and how reducing ultra-processed foods with dietitian guidance helps children and teens with Crohn's disease stay in remission longer.
-
Endoscopic stricturotomy vs balloon dilation for small bowel Crohn’s stricture
This trial tests whether endoscopic stricturotomy can be safely and effectively used to treat small bowel fibrotic strictures in Crohn’s disease, compared with endoscopic balloon dilation.
-
Prediction of postoperative recurrence in Crohn's disease after surgery
A multicenter study will test a multimodal model to predict which Crohn's patients are likely to have disease recur after intestinal resection.
-
Perianal fistula imaging comparison using TPUS, MRI, EUS, and EUA
This study tests how well four imaging methods—transperineal ultrasound, MRI, endoscopic ultrasound, and examination under anesthesia—detect and describe perianal fistulas in adults with Crohn's disease or unknown cause.
-
Familial IBD Early Risk
This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.
-
Impact of sucralose on gut health in Crohn's disease
This study tests whether the non-nutritive sweetener sucralose changes gut bacteria in adults with Crohn's disease compared to healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.